FDA clears Novaliq’s Investigational New Drug application for NOV05 | Optometry Times - Clinical News

Published on January 29, 2026
This enables the initiation of the EYETAC phase II clinical trial (NCT07285070) in patients with non-infectious anterior uveitis (NIAU).
Continue reading on website
Other news

Zeiss, 20/20 Magazine Unveil 12 Free CE Course Descriptions Ahead of Eyewear Design Week Event

January 29, 2026
NEW YORK—As part of the Eyewear Design Week 2026 collaboration between The Accessories Council (Ac) and Jobson Publishing, as reported in VMAIL in October 2025, Zeiss will exclusively present a free three-day continuing education event, featuring 12 NYSSO and ABO-approved courses. The event, which will take place March 5 through 7 at 208 W 30th Street, Suite 801, in New York City, will include cou

Eye care sector must show support for glaucoma care bill, Specsavers says

January 29, 2026
Giles Edmonds, Specsavers clinical services director, has emphasised the importance of community optometry’s support after the Glaucoma Care: England Bill was presented to Parliament on 20 January